These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18474739)

  • 1. Increased osteopontin levels in the cerebrospinal fluid of patients with multiple sclerosis.
    Braitch M; Nunan R; Niepel G; Edwards LJ; Constantinescu CS
    Arch Neurol; 2008 May; 65(5):633-5. PubMed ID: 18474739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients.
    Wen SR; Liu GJ; Feng RN; Gong FC; Zhong H; Duan SR; Bi S
    J Neuroimmunol; 2012 Mar; 244(1-2):94-6. PubMed ID: 22329905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
    PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of CSF multiple assay in multiple sclerosis: A single center experience.
    De Fino C; Lucchini M; Lucchetti D; Nociti V; Losavio FA; Bianco A; Colella F; Ricciardi-Tenore C; Sgambato A; Mirabella M
    Mult Scler Relat Disord; 2019 Oct; 35():176-181. PubMed ID: 31394405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid IL-12p40, CXCL13 and IL-8 as a combinatorial biomarker of active intrathecal inflammation.
    Bielekova B; Komori M; Xu Q; Reich DS; Wu T
    PLoS One; 2012; 7(11):e48370. PubMed ID: 23226202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development.
    Kivisäkk P; Healy BC; Francois K; Gandhi R; Gholipour T; Egorova S; Sevdalinova V; Quintana F; Chitnis T; Weiner HL; Khoury SJ
    Mult Scler; 2014 Apr; 20(4):438-44. PubMed ID: 24005026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis.
    Berg-Hansen P; Vandvik B; Fagerhol M; Holmøy T
    J Neuroimmunol; 2009 Nov; 216(1-2):98-102. PubMed ID: 19800696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers.
    Vogt MH; ten Kate J; Drent RJ; Polman CH; Hupperts R
    Mult Scler; 2010 Apr; 16(4):443-9. PubMed ID: 20086024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.
    Strehlow F; Bauer S; Martus P; Weller M; Roth P; Schlegel U; Seidel S; Scheibenbogen C; Korfel A; Kreher S
    J Neurooncol; 2016 Aug; 129(1):165-71. PubMed ID: 27294357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis.
    Börnsen L; Khademi M; Olsson T; Sørensen PS; Sellebjerg F
    Mult Scler; 2011 Jan; 17(1):32-42. PubMed ID: 20921238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.
    Agah E; Zardoui A; Saghazadeh A; Ahmadi M; Tafakhori A; Rezaei N
    PLoS One; 2018; 13(1):e0190252. PubMed ID: 29346446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis.
    Tortorella C; Direnzo V; Ruggieri M; Zoccolella S; Mastrapasqua M; D'Onghia M; Paolicelli D; Cuonzo FD; Gasperini C; Trojano M
    Mult Scler; 2018 Jul; 24(8):1039-1045. PubMed ID: 28537100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers.
    Khademi M; Bornsen L; Rafatnia F; Andersson M; Brundin L; Piehl F; Sellebjerg F; Olsson T
    Eur J Neurol; 2009 Apr; 16(4):528-36. PubMed ID: 19220425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid IL-10 as an early stage discriminative marker between multiple sclerosis and neuro-Behçet disease.
    Belghith M; Bahrini K; Kchaou M; Maghrebi O; Belal S; Barbouche MR
    Cytokine; 2018 Aug; 108():160-167. PubMed ID: 29625335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of plasma Osteopontin level in relapsing- remitting multiple sclerosis patients compared to healthy subjects in Isfahan Province.
    Jafarinia M; Sadeghi E; Alsahebfosoul F; Etemadifar M; Jahanbani-Ardakani H
    Int J Neurosci; 2020 May; 130(5):493-498. PubMed ID: 31795798
    [No Abstract]   [Full Text] [Related]  

  • 17. Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.
    Khademi M; Dring AM; Gilthorpe JD; Wuolikainen A; Al Nimer F; Harris RA; Andersson M; Brundin L; Piehl F; Olsson T; Svenningsson A
    PLoS One; 2013; 8(5):e63172. PubMed ID: 23667585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated CHI3L1 and OPN levels in patients with anti-N-methyl-d-aspartate receptor encephalitis.
    Zhao J; Wang C; Zhang Y; Sun R; Wang H; Li G; Zhang J
    J Neuroimmunol; 2019 Sep; 334():577005. PubMed ID: 31310926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin in the Cerebrospinal Fluid of Patients with Severe Aneurysmal Subarachnoid Hemorrhage.
    Abate MG; Moretto L; Licari I; Esposito T; Capuano L; Olivieri C; Benech A; Brucoli M; Avanzi GC; Cammarota G; Dianzani U; Clemente N; Panzarasa G; Citerio G; Carfagna F; Cappellano G; Della Corte F; Vaschetto R
    Cells; 2019 Jul; 8(7):. PubMed ID: 31295895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased osteopontin in muscle and serum from patients with idiopathic inflammatory myopathies.
    Xiao F; Tan JZ; Xu X; Zhu BL; Fang S; Wang XF
    Clin Exp Rheumatol; 2015; 33(3):399-404. PubMed ID: 25936410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.